Suven Life Sciences Limited (NSE:SUVEN)
India flag India · Delayed Price · Currency is INR
138.45
-0.84 (-0.60%)
Feb 2, 2026, 3:29 PM IST

Suven Life Sciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
-1,607-1,051-1,183-1,220-721.51
Depreciation & Amortization
57.9264.7565.1743.743.31
Other Amortization
0.30.270.260.230.15
Loss (Gain) From Sale of Investments
-49.76-45.49-17.92-3.56-0.61
Stock-Based Compensation
12.75----
Other Operating Activities
-55.45-192.35-139.46-56.52-134.54
Change in Accounts Receivable
-0.51-4.794.914.645.09
Change in Inventory
4.71-7.080.221.19-1.42
Change in Accounts Payable
31.594.03-3.22-10.09-27.86
Change in Other Net Operating Assets
64.8676.73112.9-35.02-122.85
Operating Cash Flow
-1,541-1,155-1,160-1,275-960.24
Capital Expenditures
-372.76--28.95-197.72-63.05
Sale of Property, Plant & Equipment
-24.21---
Investment in Securities
1,871757.32-2,512-447.21912.77
Other Investing Activities
51.59162.8362.648.14-297.11
Investing Cash Flow
1,550944.36-2,478-222.29558.4
Long-Term Debt Repaid
-7.1-8.96-16.03-15.55-12.49
Total Debt Repaid
-7.1-8.96-16.03-15.55-12.49
Net Debt Issued (Repaid)
-7.1-8.96-16.03-15.55-12.49
Issuance of Common Stock
--3,9741,476-
Other Financing Activities
-0.47-1.58-2.62-3.95361.05
Financing Cash Flow
-7.56-10.543,9551,457348.56
Miscellaneous Cash Flow Adjustments
-0---
Net Cash Flow
0.93-220.87317.46-40.75-53.28
Free Cash Flow
-1,914-1,155-1,189-1,473-1,023
Free Cash Flow Margin
-2875.39%-987.51%-874.42%-1232.64%-727.12%
Free Cash Flow Per Share
-8.78-5.29-6.67-10.93-8.04
Cash Interest Paid
0.471.582.623.958.15
Cash Income Tax Paid
-6.05-61.7711.025.211.45
Levered Free Cash Flow
-1,252-684.75-826.32-616.13-702.41
Unlevered Free Cash Flow
-1,252-683.76-824.52-612.81-697.32
Change in Working Capital
100.6568.89114.81-39.27-147.04
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.